Transgenerational Epigenetics: Edition 2

¡ Translational Epigenetics āĻ•āĻŋāĻ¤āĻžāĻĒ 13 ¡ Academic Press
āĻ‡āĻŦā§āĻ•
518
āĻĒā§ƒāĻˇā§āĻ āĻž
āĻ¯ā§‹āĻ—ā§āĻ¯
āĻŽā§‚āĻ˛ā§āĻ¯āĻžāĻ‚āĻ•āĻ¨ āĻ†ā§°ā§ āĻĒā§°ā§āĻ¯āĻžāĻ˛ā§‹āĻšāĻ¨āĻž āĻ¸āĻ¤ā§āĻ¯āĻžāĻĒāĻ¨ āĻ•ā§°āĻž āĻšā§‹ā§ąāĻž āĻ¨āĻžāĻ‡  āĻ…āĻ§āĻŋāĻ• āĻœāĻžāĻ¨āĻ•

āĻāĻ‡ āĻ‡āĻŦā§āĻ•āĻ–āĻ¨ā§° āĻŦāĻŋāĻˇā§Ÿā§‡

Transgenerational Epigenetics, Second Edition, offers the only up-to-date, comprehensive analysis of the inheritance of epigenetic phenomena between generations with an emphasis on human disease relevance, drug discovery, and next steps in clinical translation. International experts discuss mechanisms of epigenetic inheritance, its expression in animal and plant models, and how human ailments, such as metabolic disorders and cardiovascular disease are influenced by transgenerational epigenetic inheritance. Where evidence is sufficient, epigenetic clinical interventions are proposed that may help prevent or reduce the severity of disease before offspring are born. This edition has been thoroughly revised in each disease area, featuring newly researched actors in epigenetic regulation, including long noncoding RNA in addition to histone modifications and DNA methylation. Therapeutic pathways in treating cancer and extending human longevity are also considered, as are current debates and future directions for research. - Presents a fully-updated and expanded release addressing transgenerational epigenetics, epigenetic mechanisms of gene regulation, and the role of epigenetics in human longevity and cancer - Examines the field from "bench-to-bedside", discussing basic science, disease management, current debates, and next steps in epigenetic research and drug discovery - Features chapter contributions from international experts

āĻ˛āĻŋāĻ–āĻ•ā§° āĻŦāĻŋāĻˇāĻ¯āĻŧā§‡

Dr. Tollefsbol is a Distinguished Professor of Biology and a Senior Scientist in the O’Neal Comprehensive Cancer Center, Integrative Center for Aging Research, Nutrition Obesity Research Center, University Wide Microbiome Center, and the Comprehensive Diabetes Center at the University of Alabama at Birmingham (UAB). He is Director of the UAB Cell Senescence Culture Facility which he established in 1999. Dr. Tollefsbol trained as a Postdoctoral Fellow and Assistant Research Professor with members of the National Academy of Science at Duke University and the University of North Carolina. He earned doctorates in molecular biology and osteopathic medicine from the University of North Texas Health Sciences Center and his bachelor’s degree in Biology from the University of Houston. He has received prior funding from the NCI, NHLBI, NIMH and other federal institutes as well as the Glenn Foundation for Medical Research, Susan G. Komen for the Cure, the American Federation for Aging Research (AFAR), and the American Institute for Cancer Research (AICR) among many other sources.

āĻāĻ‡ āĻ‡āĻŦā§āĻ•āĻ–āĻ¨āĻ• āĻŽā§‚āĻ˛ā§āĻ¯āĻžāĻ‚āĻ•āĻ¨ āĻ•ā§°āĻ•

āĻ†āĻŽāĻžāĻ• āĻ†āĻĒā§‹āĻ¨āĻžā§° āĻŽāĻ¤āĻžāĻŽāĻ¤ āĻœāĻ¨āĻžāĻ“āĻ•āĨ¤

āĻĒāĻĸāĻŧāĻžā§° āĻ¨āĻŋāĻ°ā§āĻĻā§‡āĻļāĻžā§ąāĻ˛ā§€

āĻ¸ā§āĻŽāĻžā§°ā§āĻŸāĻĢ’āĻ¨ āĻ†ā§°ā§ āĻŸā§‡āĻŦāĻ˛ā§‡āĻŸ
Android āĻ†ā§°ā§ iPad/iPhoneā§° āĻŦāĻžāĻŦā§‡ Google Play Books āĻāĻĒāĻŸā§‹ āĻ‡āĻ¨āĻˇā§āĻŸāĻ˛ āĻ•ā§°āĻ•āĨ¤ āĻ‡ āĻ¸ā§āĻŦāĻ¯āĻŧāĻ‚āĻ•ā§āĻ°āĻŋāĻ¯āĻŧāĻ­āĻžā§ąā§‡ āĻ†āĻĒā§‹āĻ¨āĻžā§° āĻāĻ•āĻžāĻ‰āĻŖā§āĻŸā§° āĻ¸ā§ˆāĻ¤ā§‡ āĻ›āĻŋāĻ‚āĻ• āĻšāĻ¯āĻŧ āĻ†ā§°ā§ āĻ†āĻĒā§āĻ¨āĻŋ āĻ¯'āĻ¤ā§‡ āĻ¨āĻžāĻĨāĻžāĻ•āĻ• āĻ¤'āĻ¤ā§‡āĻ‡ āĻ•ā§‹āĻ¨ā§‹ āĻ…āĻĄāĻŋāĻ…'āĻŦā§āĻ• āĻ…āĻ¨āĻ˛āĻžāĻ‡āĻ¨ āĻŦāĻž āĻ…āĻĢāĻ˛āĻžāĻ‡āĻ¨āĻ¤ āĻļā§āĻ¨āĻŋāĻŦāĻ˛ā§ˆ āĻ¸ā§āĻŦāĻŋāĻ§āĻž āĻĻāĻŋāĻ¯āĻŧā§‡āĨ¤
āĻ˛ā§‡āĻĒāĻŸāĻĒ āĻ†ā§°ā§ āĻ•āĻŽā§āĻĒāĻŋāĻ‰āĻŸāĻžā§°
āĻ†āĻĒā§āĻ¨āĻŋ āĻ•āĻŽā§āĻĒāĻŋāĻ‰āĻŸāĻžā§°ā§° ā§ąā§‡āĻŦ āĻŦā§āĻ°āĻžāĻ‰āĻœāĻžā§° āĻŦā§āĻ¯ā§ąāĻšāĻžā§° āĻ•ā§°āĻŋ Google PlayāĻ¤ āĻ•āĻŋāĻ¨āĻž āĻ…āĻĄāĻŋāĻ…'āĻŦā§āĻ•āĻ¸āĻŽā§‚āĻš āĻļā§āĻ¨āĻŋāĻŦ āĻĒāĻžā§°ā§‡āĨ¤
āĻ‡-ā§°ā§€āĻĄāĻžā§° āĻ†ā§°ā§ āĻ…āĻ¨ā§āĻ¯ āĻĄāĻŋāĻ­āĻžāĻ‡āĻš
Kobo eReadersā§° āĻĻā§°ā§‡ āĻ‡-āĻšāĻŋā§ŸāĻžāĻāĻšā§€ā§° āĻĄāĻŋāĻ­āĻžāĻ‡āĻšāĻ¸āĻŽā§‚āĻšāĻ¤ āĻĒā§āĻŋāĻŦāĻ˛ā§ˆ, āĻ†āĻĒā§āĻ¨āĻŋ āĻāĻŸāĻž āĻĢāĻžāĻ‡āĻ˛ āĻĄāĻžāĻ‰āĻ¨āĻ˛â€™āĻĄ āĻ•ā§°āĻŋ āĻ¸ā§‡āĻ‡āĻŸā§‹ āĻ†āĻĒā§‹āĻ¨āĻžā§° āĻĄāĻŋāĻ­āĻžāĻ‡āĻšāĻ˛ā§ˆ āĻ¸ā§āĻĨāĻžāĻ¨āĻžāĻ¨ā§āĻ¤ā§°āĻŖ āĻ•ā§°āĻŋāĻŦ āĻ˛āĻžāĻ—āĻŋāĻŦāĨ¤ āĻ¸āĻŽā§°ā§āĻĨāĻŋāĻ¤ āĻ‡-ā§°āĻŋāĻĄāĻžā§°āĻ˛ā§ˆ āĻĢāĻžāĻ‡āĻ˛āĻŸā§‹ āĻ•ā§‡āĻ¨ā§‡āĻ•ā§ˆ āĻ¸ā§āĻĨāĻžāĻ¨āĻžāĻ¨ā§āĻ¤ā§° āĻ•ā§°āĻŋāĻŦ āĻœāĻžāĻ¨āĻŋāĻŦāĻ˛ā§ˆ āĻ¸āĻšāĻžāĻ¯āĻŧ āĻ•ā§‡āĻ¨ā§āĻĻā§ā§°āĻ¤ āĻĨāĻ•āĻž āĻ¸āĻŦāĻŋāĻļā§‡āĻˇ āĻ¨āĻŋā§°ā§āĻĻā§‡āĻļāĻžā§ąāĻ˛ā§€ āĻšāĻžāĻ“āĻ•āĨ¤

āĻ›āĻŋā§°āĻŋāĻœāĻŸā§‹ āĻ…āĻŦā§āĻ¯āĻžāĻšāĻ¤ ā§°āĻžāĻ–āĻ•

Trygve O. Tollefsbolā§° āĻĻā§āĻŦāĻžā§°āĻž āĻ†ā§°ā§ āĻ…āĻ§āĻŋāĻ•

āĻāĻ•ā§‡āĻ§ā§°āĻŖā§° āĻ‡-āĻŦā§āĻ•